ARZNEIMITTELABGABEVORRICHTUNG

Patent europeic · EP3302634 · En vigur

Inscripziun en il register

Numer da publicaziun
EP3302634
Numer da la dumonda
EP16726332
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
En vigur
Scrittira da patent
Concedì
Annunzià
02-06-2016
Publitgà
11-04-2018
Concedì
29-10-2025
La protecziun finescha il pli tard
01-06-2036
Proxima taxa annuala scadenta
30-06-2027
Classas IPC
A61M 5/20 (2006.01)
A61M 5/315 (2006.01)
Prioritad
EP 15170593 03.06.2015
Dumonda PCT
PCT/EP2016/062456 02.06.2016
Publicaziun PCT
WO2016/193350 08.12.2016
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 09-09-2026

    Midada

    Published in Swissreg on 09.09.2026

  2. 01-07-2026

    Next annual fee due on

    Next annual fee due on
    30.06.2026 → 30.06.2027

    Published in Swissreg on 01.07.2026

  3. 29-10-2025

    Concedì

    Specification status
    Non-published patent application → Granted patent
    Status of protective title
    Initiated → Active

    Published in Swissreg on 29.10.2025

Partidas

Possessur

Sanofi-Aventis Deutschland GmbH

Brüningstraße 50, 65929 Frankfurt am Main, DE

Inventur

KEMP, Thomas Mark

Ashwell Hertfordshire SG7 5LU, GB

REVELLAT, Hugo

Melbourn, Herts SG8 6DP, GB

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.